Acceptance and Commitment Therapy (ACT) - Based Treatment Development for Cancer Patients Treated for Pain

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03910296

Enrollment

Registered

2019-04-10

Start date

2019-02-20

Completion date

2021-07-30

Last updated

2022-05-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Keywords

Cancer

Brief summary

The purpose of this research study is to develop a psychological treatment for patients with cancer, focused on the psychological symptoms they experience during opioid therapy.

Detailed description

This research study is a treatment development study, which is the first time investigators are developing this psychological intervention in patients with cancer, on opioid therapy. This study is being conducted to develop a psychological intervention designed specifically for individuals with cancer. The purpose of this study is to determine how practical this intervention is, to determine patient satisfaction, and test the study procedures.

Interventions

BEHAVIORALAcceptance & Commitment Therapy

ACT is a unique, third-wave therapy that uses metaphors and experiential exercises to encourage contact with previously avoided thoughts, feelings, and behaviors.

Study design

Observational model

OTHER

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* must be at least 18 years of age * speak and comprehend English sufficiently to be able to complete the study procedures and participate in psychotherapy in English * have been diagnosed with cancer * have an estimated survival time ≥6 months (as approximated by palliative care clinic staff) * score ≥4 on the Opioid Risk Tool (Webster & Webster, 2005) with psychosocial distress as one of the positive items.

Exclusion criteria

* untreated bipolar disorder * untreated psychotic disorders * untreated borderline personality disorder * have an estimated survival time ≤6 months (as approximated by clinic staff).

Design outcomes

Primary

Measure	Time frame	Description
Study feasibility	2 years	Defined by participants' completion of 80% of measures

Secondary

Measure	Time frame	Description
Intervention acceptability	2 years	Defined by participant responses on the semi-structured qualitative interviews, upon treatment completion.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026